A detailed history of Vident Advisory, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Vident Advisory, LLC holds 1,669 shares of DGX stock, worth $228,803. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,669
Previous 115,115 98.55%
Holding current value
$228,803
Previous $15.3 Billion 98.51%
% of portfolio
0.01%
Previous 0.32%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$125.91 - $144.34 $14.3 Million - $16.4 Million
-113,446 Reduced 98.55%
1,669 $228 Million
Q1 2024

May 14, 2024

BUY
$123.78 - $142.11 $13.4 Million - $15.4 Million
108,523 Added 1646.28%
115,115 $15.3 Billion
Q4 2023

Feb 14, 2024

BUY
$120.62 - $141.12 $587,540 - $687,395
4,871 Added 283.03%
6,592 $909 Million
Q3 2023

Feb 21, 2024

SELL
$121.86 - $144.92 $593,580 - $705,905
-4,871 Reduced 73.89%
1,721 $210 Million
Q3 2023

Nov 14, 2023

BUY
$121.86 - $144.92 $209,721 - $249,407
1,721 New
1,721 $210 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.